324 related articles for article (PubMed ID: 21075356)
21. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.
Ebrahimi CM; Sheen TR; Renken CW; Gottlieb RA; Doran KS
Infect Immun; 2011 Jul; 79(7):2510-8. PubMed ID: 21518787
[TBL] [Abstract][Full Text] [Related]
22. Targeted silencing of anthrax toxin receptors protects against anthrax toxins.
Arévalo MT; Navarro A; Arico CD; Li J; Alkhatib O; Chen S; Diaz-Arévalo D; Zeng M
J Biol Chem; 2014 May; 289(22):15730-8. PubMed ID: 24742682
[TBL] [Abstract][Full Text] [Related]
23. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins.
Rivera J; Cordero RJ; Nakouzi AS; Frases S; Nicola A; Casadevall A
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19002-7. PubMed ID: 20956325
[TBL] [Abstract][Full Text] [Related]
24. Targeting Bacillus anthracis toxicity with a genetically selected inhibitor of the PA/CMG2 protein-protein interaction.
Male AL; Forafonov F; Cuda F; Zhang G; Zheng S; Oyston PCF; Chen PR; Williamson ED; Tavassoli A
Sci Rep; 2017 Jun; 7(1):3104. PubMed ID: 28596569
[TBL] [Abstract][Full Text] [Related]
25. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
Drysdale M; Olson G; Koehler TM; Lipscomb MF; Lyons CR
Infect Immun; 2007 Apr; 75(4):1757-64. PubMed ID: 17242059
[TBL] [Abstract][Full Text] [Related]
26. New insights into the functions of anthrax toxin.
Banks DJ; Ward SC; Bradley KA
Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
[TBL] [Abstract][Full Text] [Related]
27. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
[TBL] [Abstract][Full Text] [Related]
28. Receptor-specific requirements for anthrax toxin delivery into cells.
Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341
[TBL] [Abstract][Full Text] [Related]
29. The dark sides of capillary morphogenesis gene 2.
Deuquet J; Lausch E; Superti-Furga A; van der Goot FG
EMBO J; 2012 Jan; 31(1):3-13. PubMed ID: 22215446
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis.
Bradburne C; Chung MC; Zong Q; Schlauch K; Liu D; Popova T; Popova A; Bailey C; Soppet D; Popov S
BMC Immunol; 2008 Nov; 9():67. PubMed ID: 19014542
[TBL] [Abstract][Full Text] [Related]
31. Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.
Hutt JA; Lovchik JA; Drysdale M; Sherwood RL; Brasel T; Lipscomb MF; Lyons CR
Am J Pathol; 2014 Dec; 184(12):3205-16. PubMed ID: 25285720
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the interaction between anthrax toxin and its cellular receptors.
Liu S; Leung HJ; Leppla SH
Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
[TBL] [Abstract][Full Text] [Related]
33. The roles of anthrax toxin in pathogenesis.
Moayeri M; Leppla SH
Curr Opin Microbiol; 2004 Feb; 7(1):19-24. PubMed ID: 15036135
[TBL] [Abstract][Full Text] [Related]
34. Anthrax Edema and Lethal Toxins Differentially Target Human Lung and Blood Phagocytes.
Patel VI; Booth JL; Dozmorov M; Brown BR; Metcalf JP
Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32698436
[No Abstract] [Full Text] [Related]
35. Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.
Wycoff KL; Belle A; Deppe D; Schaefer L; Maclean JM; Haase S; Trilling AK; Liu S; Leppla SH; Geren IN; Pawlik J; Peterson JW
Antimicrob Agents Chemother; 2011 Jan; 55(1):132-9. PubMed ID: 20956592
[TBL] [Abstract][Full Text] [Related]
36. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
[TBL] [Abstract][Full Text] [Related]
37. Anthrax lethal factor inhibition.
Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
[TBL] [Abstract][Full Text] [Related]
38. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
[TBL] [Abstract][Full Text] [Related]
39. Bacillus anthracis genomic DNA enhances lethal toxin-induced cytotoxicity through TNF-α production.
Jeon JH; Kim YH; Choi MK; Kim KA; Lee HR; Jang J; Kim YR; Chun JH; Eo SK; Kim TS; Rhie GE
BMC Microbiol; 2014 Dec; 14():300. PubMed ID: 25472474
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
